WULF - S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday | Benzinga
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Truist Securities raised the price target for Belden Inc. (NYSE:BDC) from $119 to $123. Truist Securities analyst William Stein maintained a Buy rating. Belden shares rose 0.5% to close at $92.30 on Wednesday. See how other analysts view this stock.
- Baird boosted the price target for Quest Diagnostics Incorporated (NYSE:DGX) from $145 to $153. Baird analyst Eric Coldwell maintained a Neutral rating. Quest Diagnostics shares gained 3.1% to close at $140.90 on Wednesday. See how other analysts view this stock.
- HC Wainwright & Co. slashed Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) price target from $90 to $60. HC Wainwright & Co. analyst Patrick Trucchio maintained a Buy rating. Arrowhead Pharmaceuticals shares fell 0.6% to close at $25.07 on Wednesday. See ...